NCT04003649 Evaluate IL13Rα2-Targeted Chimeric Antigen Receptor (CAR) T Cells Combined with Checkpoint Inhibition for Patients with Resectable Recurrent Glioblastoma. Here, IL13RA2 is linked to glioblastoma.